Determination of RP-HPLC Method for Safinamide: Its Bulk and Tablet Dosage Form

Authors

  • S. K. Godasu Assist Professor Sree indhu institute of Pharmacy Sheriguda Ibrahimpatnam Ranga Reddy-501510 India.
  • V. Rajashakhar Assist professor in Anurag pharmacy college
  • G.S.V. D. Jyothi
  • Supraja .
  • Pravallika Priya Principal in Sree dattha institute of pharmacy
  • Santhosh4 .

DOI:

https://doi.org/10.37591/rrjodfdp.v5i3.163

Keywords:

Safinamide, RP-HPLC

Abstract

A new method was established for estimation of Safinamide by RP-HPLC method. The chromatographic conditions were successfully developed for the separation of Safinamide by using Agilent C18 column (4.6×150 mm, 5 µ); flow rate was 1 ml/min, mobile phase ratio was Methnol, Acetonitril (60:40), pH 3 (pH was adjusted with orthophosphoric acid), detection wavelength was 235 nm. The instrument used was WATERS HPLC Auto Sampler, Separation module 2695, photo diode array detector 996, Empower-software version-2. The retention times were found to be 2.305 min. The % purity of Safinamide was found to be 99.54%. The system suitability parameters for Safinamide such as theoretical plates and tailing factor were found to be 4600 and 1.4. The analytical method was validated according to ICH guidelines (ICH, Q2 (R1)). The linearity study of Safinamide was found in a concentration range of 5–25 µg and correlation coefficient (r2) were found to be 0.998, % recovery were found to be 99.48%, %RSD for repeatability was 0.17, % RSD for intermediate precision was 0.1. LOD value was 0.303 and LOQ value was 1.011. Hence the suggested RP-HPLC method can be used for routine analysis of Safinamide in API and pharmaceutical dosage form.

 

Keywords: Safinamide, RP-HPLC

 

Cite this Article

Godasu SK, Rajashakar V, Jyothi GSVD, et al. Determination of RP-HPLC Method for Safinamide: Its Bulk and Tablet Dosage Form. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2018; 5(3): 1–6p.

Downloads

Published

2019-01-30

Issue

Vol. 5 No. 3 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.